Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen S Yee

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|April 8, 2010
YAP1--friend and foeKaren S Yee, Eric O'Neill
Apoptosis : an International Journal on Programmed Cell Death|October 31, 2007
Contribution of membrane localization to the apoptotic activity of PUMAKaren S Yee, Karen H Vousden
Carcinogenesis|May 13, 2005
Complicating the complexity of p53Karen S Yee, Karen H Vousden
Assessment|September 14, 2019
Projected Retained Ability Score (PRAS): A New Methodology for Quantifying Absolute Change in Norm-Based Psychological Test Scores Over TimeWilliam G Kronenberger, Magdalena Harrington, Karen S Yee
Avian Pathology : Journal of the W.V.P.A|January 22, 2009
Transmission of low-pathogenicity avian influenza virus of subtype H6N2 from chickens to Pekin ducks and Japanese quail (Coturnix coturnix japonica)Karen S Yee, Carol J Cardona, Tim E Carpenter
Comparative Immunology, Microbiology and Infectious Diseases|May 2, 2008
Epidemiology of H5N1 avian influenzaKaren S Yee, Tim E Carpenter, Carol J Cardona
Current Biology : CB|December 8, 2009
ATM regulates a RASSF1A-dependent DNA damage responseGarth Hamilton, Karen S Yee, Simon Scrace, et al.
Orphanet Journal of Rare Diseases|December 5, 2021
Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis IIKaren S Yee, Yanyu Wu, Magdalena Harrington, et al.
Journal of Health Economics and Outcomes Research|May 27, 2022
Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart ReviewOlulade Ayodele, Kersten Müller, Solmaz Setayeshgar, et al.
Orphanet Journal of Rare Diseases|March 11, 2024
Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis IIKaren S Yee, Sandy Lewis, Emily Evans, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|April 8, 2010
YAP1--friend and foeKaren S Yee, Eric O'Neill
Apoptosis : an International Journal on Programmed Cell Death|October 31, 2007
Contribution of membrane localization to the apoptotic activity of PUMAKaren S Yee, Karen H Vousden
Carcinogenesis|May 13, 2005
Complicating the complexity of p53Karen S Yee, Karen H Vousden
Assessment|September 14, 2019
Projected Retained Ability Score (PRAS): A New Methodology for Quantifying Absolute Change in Norm-Based Psychological Test Scores Over TimeWilliam G Kronenberger, Magdalena Harrington, Karen S Yee
Avian Pathology : Journal of the W.V.P.A|January 22, 2009
Transmission of low-pathogenicity avian influenza virus of subtype H6N2 from chickens to Pekin ducks and Japanese quail (Coturnix coturnix japonica)Karen S Yee, Carol J Cardona, Tim E Carpenter
Comparative Immunology, Microbiology and Infectious Diseases|May 2, 2008
Epidemiology of H5N1 avian influenzaKaren S Yee, Tim E Carpenter, Carol J Cardona
Current Biology : CB|December 8, 2009
ATM regulates a RASSF1A-dependent DNA damage responseGarth Hamilton, Karen S Yee, Simon Scrace, et al.
Orphanet Journal of Rare Diseases|December 5, 2021
Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis IIKaren S Yee, Yanyu Wu, Magdalena Harrington, et al.
Journal of Health Economics and Outcomes Research|May 27, 2022
Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart ReviewOlulade Ayodele, Kersten Müller, Solmaz Setayeshgar, et al.
Orphanet Journal of Rare Diseases|March 11, 2024
Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis IIKaren S Yee, Sandy Lewis, Emily Evans, et al.
Pageof 4